Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katarzyna, Gliniewicz"'
Autor:
Cybulski, Katarzyna Gliniewicz, Wojciech Kluźniak, Dominika Wokołorczyk, Tomasz Huzarski, Klaudia Stempa, Helena Rudnicka, Anna Jakubowska, Marek Szwiec, Joanna Jarkiewicz-Tretyn, Mariusz Naczk, Tomasz Kluz, Tadeusz Dębniak, Jacek Gronwald, Jan Lubiński, Steven A. Narod, Mohammad R. Akbari, Cezary
Publikováno v:
Genes; Volume 14; Issue 7; Pages: 1329
The APOBEC3B gene belongs to a cluster of DNA-editing enzymes on chromosome 22 and encodes an activation-induced cytidine deaminase. A large deletion of APOBEC3B was associated with increased breast cancer risk, but the evidence is inconclusive. To i
Autor:
Sylwia Morawska, Pawel Domagala, Marek Szwiec, Steven A. Narod, Tomasz Huzarski, Aniruddh Kashyap, Jacek Gronwald, Jan Lubinski, Cezary Cybulski, Dominika Wokołorczyk, Katarzyna Gliniewicz, Anna Jakubowska, Wojciech Kluźniak, Mohammad R. Akbari, Agata Szymiczek, Klaudia Stempa, Tadeusz Dębniak, Bogna Rusak
Publikováno v:
International Journal of Cancer. 147:2793-2800
In designing national strategies for genetic testing, it is important to define the full spectrum of pathogenic mutations in prostate cancer (PCa) susceptibility genes. To investigate the frequency of mutations in PCa susceptibility genes in Polish f
Autor:
Helena Rudnicka, Klaudia Stempa, Mariusz Naczk, Wojciech Kluźniak, Karolina Malińska, Cezary Cybulski, Anna Jakubowska, Emilia Rogoża-Janiszewska, Joanna Tomiczek-Szwiec, Piotr Kozlowski, Tomasz Huzarski, Marcin Lener, Katarzyna Gliniewicz, Malwina Suszynska, Tomasz Kluz, Tadeusz Dębniak, Jacek Gronwald, Pawel Domagala, Mohammad R. Akbari, Steven A. Narod, Jan Lubinski, Dominika Wokołorczyk
Publikováno v:
Cancers
Volume 13
Issue 21
Cancers, Vol 13, Iss 5464, p 5464 (2021)
Volume 13
Issue 21
Cancers, Vol 13, Iss 5464, p 5464 (2021)
Simple Summary Current cancer testing gene panels tend to be comprehensive. One of the genes commonly included in the testing panels is BARD1. To establish whether BARD1 mutations predispose to prostate cancer, we sequenced BARD1 in 390 hereditary pr
Autor:
Wojciech Kluźniak, Jacek Gronwald, Aniruddh Kashyap, Anna Jakubowska, Steven A. Narod, Katarzyna Gliniewicz, Dominika Wokołorczyk, Klaudia Stempa, Bogna Rusak, Mohammad R. Akbari, Sylwia Morawska, Pawel Domagala, Marek Szwiec, Tadeusz Dębniak, Jan Lubinski, Tomasz Huzarski, Cezary Cybulski
Publikováno v:
Br J Cancer
BACKGROUND: The objective of this study was to establish the contribution of PALB2 mutations to prostate cancer risk and to estimate survival among PALB2 carriers. METHODS: We genotyped 5472 unselected men with prostate cancer and 8016 controls for t
Autor:
Dominika, Wokołorczyk, Wojciech, Kluźniak, Tomasz, Huzarski, Jacek, Gronwald, Agata, Szymiczek, Bogna, Rusak, Klaudia, Stempa, Katarzyna, Gliniewicz, Aniruddh, Kashyap, Sylwia, Morawska, Tadeusz, Dębniak, Anna, Jakubowska, Marek, Szwiec, Paweł, Domagała, Jan, Lubiński, Steven A, Narod, Mohammad R, Akbari, Cezary, Cybulski
Publikováno v:
International journal of cancerREFERENCES. 147(10)
In designing national strategies for genetic testing, it is important to define the full spectrum of pathogenic mutations in prostate cancer (PCa) susceptibility genes. To investigate the frequency of mutations in PCa susceptibility genes in Polish f
Autor:
Dominika Wokołorczyk, Jacek Gronwald, Klaudia Stempa, Mohammad R. Akbari, Jan Lubinski, Cezary Cybulski, Bogna Rusak, Steven A. Narod, Sylwia Morawska, Aniruddh Kashyap, Tomasz Huzarski, Małgorzata Stawicka, Helena Rudnicka, Marek Szwiec, Anna Jakubowska, Magdalena Cechowska, Wojciech Kluźniak, Joanna Jarkiewicz-Tretyn, Pawel Domagala, Karina Mordak, Marcin Lener, Katarzyna Gliniewicz, Tadeusz Dębniak
Publikováno v:
Cancers
Volume 11
Issue 10
Cancers, Vol 11, Iss 10, p 1548 (2019)
Volume 11
Issue 10
Cancers, Vol 11, Iss 10, p 1548 (2019)
Bloom Syndrome is a rare recessive disease which includes a susceptibility to various cancers. It is caused by homozygous mutations of the BLM gene. To investigate whether heterozygous carriers of a BLM mutation are predisposed to breast cancer, we s